Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

Abstract

GDNF administered by ICV injection is biologically active as evidenced by the spectrum of AE encountered in this study. GDNF did not improve parkinsonism, possibly because GDNF did not reach the target tissues--putamen and substantia nigra.